Tesamorelin - PDFSEARCH.IO - Document Search Engine

Tesamorelin
Results: 9

#	Item
1	EMAIL TUS PREGUNTAS AL www.projectinform.org/preguntas ENERO DEEl tesamorelin y el exceso Add to Reading List Source URL: www.projectinform.org Language: Spanish - Date: 2011-07-06 19:40:14
2	Microsoft Word - pdl_notice_tesamorelin_tofacitinib_ldo_avis-fra.docx Add to Reading List Source URL: hc-sc.gc.ca Language: French - Date: 2014-05-12 14:23:37
3	Microsoft Word - pdl_notice_tesamorelin_tofacitinib_ldo_avis-eng.docx Add to Reading List Source URL: hc-sc.gc.ca Language: English - Date: 2014-05-12 14:23:37 Patient safety Chemistry Immunosuppressants Clinical pharmacology Adverse effect Medical prescription Rheumatoid arthritis Methotrexate Methadone Medicine Health Pharmacology
4	PRIOR AUTHORIZATION POLICY Egrifta™ (tesamorelin injection – EMD Serono) To initiate a Coverage Review, Call[removed]OVERVIEW Egrifta is an analog of human growth hormone-releasing factor (GRF), indicated for Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2013-10-03 14:58:53 Neuroendocrinology Peptide hormones Growth hormones Growth hormone treatment Pediatrics Growth hormone Lipodystrophy HIV-associated lipodystrophy Pituitary adenoma Endocrine system Biology Medicine
5	1) Please comment on the findings of glucose intolerance and development of diabetes associated with Egrifta (tesamorelin) therapy and its impact on long-term cardiovascular risk Add to Reading List Source URL: www.fda.gov Language: English Organochlorides Fenofibrate Ketones Prodrugs Merck Statin Simvastatin Low-density lipoprotein Niacin Chemistry Organic chemistry Fibrates
6	Microsoft Word - pdl_notice_tesamorelin_tofacitinib_ldo_avis-fra.docx Add to Reading List Source URL: www.hc-sc.gc.ca Language: French - Date: 2014-05-12 14:23:37
7	Microsoft Word - pdl_notice_tesamorelin_tofacitinib_ldo_avis-eng.docx Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2014-05-12 14:23:37 Patient safety Chemistry Immunosuppressants Clinical pharmacology Adverse effect Medical prescription Rheumatoid arthritis Methotrexate Methadone Medicine Health Pharmacology
8	THERATECHNOLOGIES OBTAINS U.S. PATENT TERM EXTENSION FOR TESAMORELIN Montreal, Canada – June 9, 2014 —Theratechnologies Inc. (TSX: TH) today announced that the United States Patent and Trademark Office (USPTO) has is Add to Reading List Source URL: www.theratech.com Language: English - Date: 2014-06-10 09:56:59 Property law Term of patent in the United States Law Term of patent United States Patent and Trademark Office Patent Patent law Civil law United States patent law
9	Additional Update on Availability of EGRIFTA® (tesamorelin for injection) in the United States Montreal, Canada – May 23, 2014 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced today that following fu Add to Reading List Source URL: www.theratech.com Language: English - Date: 2014-05-23 09:05:51 Forward-looking statement Short Business Business law Communication

UPDATE